Our research study is comparing how effective 2 different FDA approved drug combinations are at reducing flareups and the risk of serious heart events in those with COPD.
Those who qualify and choose to participate could earn up to $825 in 11 visits over 3 years.
-1.jpeg?width=2000&height=2000&name=AdobeStock_310456955%20(1)-1.jpeg "AdobeStock_310456955 (1)-1")
This study is looking at how well Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF) or Glycopyrronium and Formoterol Fumarate (GFF) may help prevent COPD flare-ups and serious heart events, like heart failure and heart attacks, in people with COPD. We are also doing this study to learn more about COPD, heart problems, serious heart events, and other related conditions.
BGF and GFF are both approved to treat COPD. Everyone on the study will get BGF or GFF. No one will get a placebo.
You may be on this study from 3 months up to about 3 years (about 38 months). The study consists of up to 11 visits.
Those who qualify and choose to participate could receive:
Access to new potential drug combination aiming to reduce risk for serious heart events at no cost
Access to top-tier medical oversight from our dedicated medical team at no cost
Compensation up to $825 for 11 visits over a three-year period
.jpeg "woman checking on man with COPD")
A research study or clinical trial is the process a potential new drug, device, procedure, or process goes through to prove that it is safe, tolerable and effective for the condition it is being studied for. Research studies are the only way to advance medicine for future generations.
Each study has its own set of inclusion and exclusion criteria that a participant must meet before they are allowed to participate in a study. Patients from all backgrounds and walks of life are encouraged to participate.
Every participant in every research study must go through the informed consent process. During this, the trial doctor and research team go over what will happen in the study, what treatments you might get, how long the trial is expected to last, what happens during visits, the potential risks and benefits, and many other important facts about the study. Participants may withdraw their consent and discontinue the study at any time for any reason.
A placebo looks like a treatment but does not have any active medicine in it. Researchers use placebos to help make sure any changes in the participants’ health are actually caused by the study treatment. You do not get to choose if you get the study treatment or the placebo, and you may not know if you get the placebo until after the study. Not all research studies use a placebo.
If studies do not include diverse participants, we cannot know if treatments work for everyone who needs them. Studies only tell researchers how something works for the participants of that study, and they may not work the same in people of different races, ethnicities, ages, or sexes.
All research studies must follow federal laws and ethical guidelines, including HIPAA. Studies must also be approved by an expert group called an institutional review board (IRB) that helps make sure the trial is fair and as safe as possible, and that any risks to the participants are worth the potential benefits.